Mode
Text Size
Log in / Sign up
N/A N=53 Randomized Treatment

Development of a Resiliency Training Program for Parents of Children With Specific Learning Disabilities

Stress

Enrolled (actual)
53
Serious AEs
0.0%
Results posted
Sep 2019
Primary outcome: Primary: Distress — -1.47; .48 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Relaxation Response Resiliency Training for Parents of SPLD (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Massachusetts General Hospital
Primary completion
May 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Distress
-1.47; .48
PRIMARY
Current Experiences Scale
7.67; 1.29
SECONDARY
Stress Reactivity
7.74; -.95

Summary

This study has three aims: Phase I: Through focus group interviews with expert clinicians, leaders of organizations, and parents with children with special needs, this study aims to identify the psychosocial needs of parents of children with learning disabilities, specifically a) the types of concerns that parents find most difficult and stressful b) areas of concern that lack support and resources, and c) areas of need for education and skill training. This study also aims to gather feedback on the Benson-Henry Institute's Relaxation Response Resiliency Program (3RP). Phase II: Informed by Phase I findings, this study aims to develop and determine the feasibility and acceptability of a virtual 8-session Relaxation Response Resiliency (3RP) program for parents of children with Specific Learning Disabilities (SPLD). Phase II: This study also aims to test the effectiveness of a pilot wait-list control trial, establishing efficacy of a virtual resiliency program.

Eligibility Criteria

Inclusion Criteria

Inclusion criteria for 3RP intervention:

  • Being the parent of at least one elementary school aged child with a diagnosed specific learning disability
  • Age 18 or older

Exclusion Criteria

Exclusion criteria for participation in 3RP group:

  • Being the parent of a child with a severe mental or physical disability up to the discretion of the principal investigator
  • Unable or unwilling to sign the informed consent documents
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02772432). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search